ARDS insider filings

Aridis Pharmaceuticals, Inc. — 39 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-06-28. Screen ARDS transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ARDS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Aridis Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2024-06-284Windham-Bannister Susan Richards — DirectorGrant/award (A): 200,000 (derivative) @ $0EDGAR
2024-06-284Jafri Hasan — Chief Medical OfficerGrant/award (A): 250,000 (derivative) @ $0EDGAR
2024-06-284Patzer Eric — DirectorPurchase (P): 714,286 @ $0.07EDGAR
2024-06-284Truong Vu — CEO, DirectorPurchase (P): 714,286 @ $0.07EDGAR
2024-06-284HAMILTON JOHN F — DirectorGrant/award (A): 200,000 (derivative) @ $0EDGAR
2023-09-194Jafri Hasan — Chief Medical OfficerGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-09-194Windham-Bannister Susan Richards — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2023-09-194Patzer Eric — Executive Chairman, DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2023-09-194Truong Vu — CEO and Director, DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2023-09-194HAMILTON JOHN F — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2023-06-154Patzer Eric — Executive Chairman, DirectorOption exercise (M): 12,000 · Grant/award (A): 30,000 (derivative) @ $0 · Option exercise (M): 12,000 (derivative)EDGAR
2023-06-154Truong Vu — CEO and Director, DirectorOption exercise (M): 15,000 · Grant/award (A): 100,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative)EDGAR
2023-06-154Windham-Bannister Susan Richards — DirectorOption exercise (M): 5,000 · Grant/award (A): 15,000 (derivative) @ $0 · Option exercise (M): 5,000 (derivative)EDGAR
2023-06-154Jafri Hasan — Chief Medical OfficerOption exercise (M): 10,000 · Grant/award (A): 25,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative)EDGAR
2023-06-154KURLAND FRED — CFOOption exercise (M): 4,000 · Grant/award (A): 10,000 (derivative) @ $0 · Option exercise (M): 4,000 (derivative)EDGAR
2023-06-154HAMILTON JOHN F — DirectorOption exercise (M): 5,000 · Grant/award (A): 15,000 (derivative) @ $0 · Option exercise (M): 5,000 (derivative)EDGAR
2022-12-074Truong Vu — Chief Executive Officer, DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2022-12-074Patzer Eric — Executive Chairman, DirectorGrant/award (A): 24,000 (derivative) @ $0EDGAR
2022-12-074Jafri Hasan — Chief Medical OfficerGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-12-074Gibbs Craig S — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-12-074Windham-Bannister Susan Richards — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-12-074KURLAND FRED — Chief Financial OfficerGrant/award (A): 8,000 (derivative) @ $0EDGAR
2022-12-074HAMILTON JOHN F — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-12-074RUFFOLO ROBERT R — DirectorGrant/award (A): 10,000 (derivative) @ $0EDGAR
2022-06-084Truong Vu — CEO and Director, DirectorGrant/award (A): 88,360 (derivative) @ $0EDGAR
2021-10-054Windham-Bannister Susan Richards — DirectorGrant/award (A): 8,500 (derivative) @ $0EDGAR
2021-10-054Jafri Hasan — Chief Medical OfficerGrant/award (A): 30,000 (derivative) @ $0EDGAR
2021-10-054Gibbs Craig S — DirectorGrant/award (A): 7,900 (derivative) @ $0EDGAR
2021-10-054KURLAND FRED — CFOGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-10-054HAMILTON JOHN F — DirectorGrant/award (A): 9,400 (derivative) @ $0EDGAR
2021-10-054RUFFOLO ROBERT R — DirectorGrant/award (A): 7,000 (derivative) @ $0EDGAR
2021-09-084Jafri Hasan — Chief Medical OfficerPurchase (P): 3,009 @ $4.15 · Purchase (P): 1,991 @ $4.15 · Purchase (P): 100 @ $3.97EDGAR
2021-07-274Truong Vu — CEO, DirectorPurchase (P): 5,000 @ $5.11EDGAR
2021-07-274Patzer Eric — DirectorPurchase (P): 5,175 @ $4.84EDGAR
2021-07-274HAMILTON JOHN F — DirectorPurchase (P): 2,000 @ $4.87EDGAR
2021-05-134Truong Vu — CEO and Director, DirectorGrant/award (A): 53,340 (derivative) @ $0EDGAR
2021-04-024Jafri Hasan — Chief Medical OfficerGrant/award (A): 10,000 (derivative) @ $0EDGAR
2021-02-224Nazak Michael Adrian — Chief Financial OfficerOption exercise (M): 20,000 (derivative) @ $0EDGAR
2021-02-184Patzer Eric — Chairman, Director, 10% ownerGift (G): 16,000 @ $0EDGAR

Recent 8-K events — Aridis Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-06-278-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-168-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2023-12-188-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-038-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-09-078-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2023-08-258-K1.02 — Termination of a Material Definitive AgreementEDGAR
2023-08-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-07-208-K2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementEDGAR
2023-07-188-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2023-06-238-K4.01 — Changes in Registrant's Certifying AccountantEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ARDS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs